Provided by Tiger Fintech (Singapore) Pte. Ltd.

TherapeuticsMD

1.25
+0.140012.61%
Post-market: 1.19-0.0600-4.80%19:19 EDT
Volume:151.42K
Turnover:190.95K
Market Cap:14.47M
PE:-6.70
High:1.36
Open:1.13
Low:1.13
Close:1.11
Loading ...
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2024

Major Issues Report

Form 8-K - Current report
Apr 29, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]